MedPath

UNIVERSITY OF CINCINNATI

πŸ‡ΊπŸ‡ΈUnited States
Ownership
-
Established
1819-01-01
Employees
5.9K
Market Cap
-
Website
https://www.uc.edu/

Palliative UNConventional Hypofractionation Trial for Metastatic Bone Disease

Phase 3
Recruiting
Conditions
Metastatic Bone Tumor
Interventions
Radiation: Experimental Radiation Dose
Radiation: Conventional Radiation Dose
First Posted Date
2021-11-10
Last Posted Date
2023-09-18
Lead Sponsor
University of Cincinnati
Target Recruit Count
168
Registration Number
NCT05115331
Locations
πŸ‡ΊπŸ‡Έ

University of Cincinnati, Cincinnati, Ohio, United States

ROSE-Longitudinal Assessment With Neuroimaging

Recruiting
Conditions
Intracerebral Hemorrhage
First Posted Date
2021-10-22
Last Posted Date
2023-05-12
Lead Sponsor
University of Cincinnati
Target Recruit Count
250
Registration Number
NCT05089331
Locations
πŸ‡ΊπŸ‡Έ

Columbia University, New York, New York, United States

πŸ‡ΊπŸ‡Έ

Baptist Health Louisville, Louisville, Kentucky, United States

πŸ‡ΊπŸ‡Έ

University of Illinois Chicago, Chicago, Illinois, United States

and more 4 locations

The Wright Center of Innovation Imaging Archive

Active, not recruiting
Conditions
Medical Imaging Data
Interventions
Diagnostic Test: CT imaging exam
Diagnostic Test: MRI exam
Diagnostic Test: PET/CT imaging exam
First Posted Date
2021-10-12
Last Posted Date
2024-01-18
Lead Sponsor
University of Cincinnati
Target Recruit Count
10000
Registration Number
NCT05074537
Locations
πŸ‡ΊπŸ‡Έ

Martha Morehouse Medical Plaza, Columbus, Ohio, United States

Healthy Eating for My Infant (HEMI)

Not Applicable
Completed
Conditions
Pediatric Obesity
Interventions
Behavioral: Healthy Eating for My Infant
First Posted Date
2021-07-27
Last Posted Date
2025-03-19
Lead Sponsor
University of Cincinnati
Target Recruit Count
30
Registration Number
NCT04977947
Locations
πŸ‡ΊπŸ‡Έ

University of Cincinnati, Cincinnati, Ohio, United States

πŸ‡ΊπŸ‡Έ

Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States

Efficacy of Hematoma Block on Postoperative Pain After Femoral Intramedullary Rodding: A Randomized Trial

Phase 4
Completed
Conditions
Femur Fracture
Interventions
Drug: Normal Saline
First Posted Date
2021-04-27
Last Posted Date
2023-02-16
Lead Sponsor
University of Cincinnati
Target Recruit Count
88
Registration Number
NCT04860856
Locations
πŸ‡ΊπŸ‡Έ

University of Cincinnati College of Medicine, Cincinnati, Ohio, United States

Evaluating the Impact of Vocal Health Education on Mask-wearing Workers During COVID-19

Not Applicable
Completed
Conditions
Health Behavior
Interventions
Behavioral: Educational Vocal Health Modules
First Posted Date
2021-04-26
Last Posted Date
2022-01-04
Lead Sponsor
University of Cincinnati
Target Recruit Count
5
Registration Number
NCT04858542
Locations
πŸ‡ΊπŸ‡Έ

Victoria McKenna, Cincinnati, Ohio, United States

Motor Control Physical Therapist Support Stroke

Not Applicable
Completed
Conditions
Stroke
Interventions
Behavioral: Physical therapist support
First Posted Date
2021-04-23
Last Posted Date
2024-08-21
Lead Sponsor
University of Cincinnati
Target Recruit Count
25
Registration Number
NCT04856527
Locations
πŸ‡ΊπŸ‡Έ

University of Cincinnati Center for Cognition, Action, and Perception, Cincinnati, Ohio, United States

Belatacept With Early Steroid Withdrawal rATG and Everolimus in Renal Transplantation (BETTER Trial)

Phase 4
Conditions
Kidney Transplant Rejection
Interventions
First Posted Date
2021-04-19
Last Posted Date
2021-04-19
Lead Sponsor
University of Cincinnati
Target Recruit Count
120
Registration Number
NCT04849533
Locations
πŸ‡ΊπŸ‡Έ

The Christ Hospital, Cincinnati, Ohio, United States

πŸ‡ΊπŸ‡Έ

University of Cincinnati, Cincinnati, Ohio, United States

A Pharmacokinetic Analysis of Levetiracetam Prophylaxis in Critically Ill Patients With Severe Traumatic Brain Injury

Completed
Conditions
Traumatic Brain Injury
Interventions
Other: Serum Sample Collection
First Posted Date
2021-04-08
Last Posted Date
2024-02-29
Lead Sponsor
University of Cincinnati
Target Recruit Count
10
Registration Number
NCT04836481
Locations
πŸ‡ΊπŸ‡Έ

University of Cincinnati Medical Center, Cincinnati, Ohio, United States

Studies of COVID-19 Patients Treated With Oral Bismuth Subsalicylate (Pepto-Bismol)

Phase 4
Completed
Conditions
Diarrhea
COVID-19
Interventions
Drug: Bismuth Subsalicylate 262 milligram (mg) Oral Tablet, Chewable
Other: Placebo oral tablet without BSS
First Posted Date
2021-03-23
Last Posted Date
2023-03-01
Lead Sponsor
University of Cincinnati
Target Recruit Count
60
Registration Number
NCT04811339
Locations
πŸ‡ΊπŸ‡Έ

University of Louisville, Louisville, Kentucky, United States

Β© Copyright 2025. All Rights Reserved by MedPath